STRIDE INC (LRN) Stock Analyst Ratings
NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 100.16. This target is -14.05% below the current price.
LRN was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-20 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Canaccord Genuity | Initiate | Buy |
| 2024-07-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-01-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-11-16 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-10-25 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-16 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-08-16 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-08-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-04-26 | Morgan Stanley | Maintains | Equal-Weight |